Charles River Laboratories Inte - stock earnings
CRL Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 187.1 million USD | 1.0 billion USD |
| 2023Q3 | 87.4 million USD | 1.0 billion USD |
| 2023Q2 | 97.0 million USD | 1.1 billion USD |
| 2023Q1 | 103.1 million USD | 1.0 billion USD |
| 2022Q4 | 187.4 million USD | 1.1 billion USD |
| 2022Q3 | 96.5 million USD | 989.2 million USD |
| 2022Q2 | 109.3 million USD | 973.1 million USD |
| 2022Q1 | 93.0 million USD | 913.9 million USD |
| 2021Q4 | 137.6 million USD | 905.1 million USD |
| 2021Q3 | 103.4 million USD | 895.9 million USD |
| 2021Q2 | 88.4 million USD | 914.6 million USD |
| 2021Q1 | 61.5 million USD | 824.6 million USD |
| 2020Q4 | 143.2 million USD | 791.0 million USD |
| 2020Q3 | 102.9 million USD | 743.3 million USD |
| 2020Q2 | 67.4 million USD | 682.6 million USD |
| 2020Q1 | 50.8 million USD | 707.1 million USD |
| 2019Q4 | 80.3 million USD | 691.1 million USD |
| 2019Q3 | 72.8 million USD | 668.0 million USD |
| 2019Q2 | 43.7 million USD | 657.6 million USD |
| 2019Q1 | 55.1 million USD | 604.6 million USD |
| 2018Q4 | 59.7 million USD | 601.5 million USD |
| 2018Q3 | 60.4 million USD | 585.3 million USD |
| 2018Q2 | 53.7 million USD | 585.3 million USD |
| 2018Q1 | 52.6 million USD | 494.0 million USD |
| 2017Q4 | -29.8 million USD | 478.5 million USD |
| 2017Q3 | 52.5 million USD | 464.2 million USD |
| 2017Q2 | 54.0 million USD | 469.1 million USD |
| 2017Q1 | 46.8 million USD | 445.8 million USD |
| 2016Q4 | 44.7 million USD | 466.8 million USD |
| 2016Q3 | 37.7 million USD | 425.7 million USD |
| 2016Q2 | 35.2 million USD | 434.1 million USD |
| 2016Q1 | 37.1 million USD | 354.9 million USD |
| 2015Q4 | 31.9 million USD | 353.9 million USD |
| 2015Q3 | 37.4 million USD | 349.5 million USD |
| 2015Q2 | 48.5 million USD | 339.6 million USD |
| 2015Q1 | 31.5 million USD | 320.4 million USD |
| 2014Q4 | 27.2 million USD | 329.5 million USD |
| 2014Q3 | 32.0 million USD | 327.6 million USD |
| 2014Q2 | 35.3 million USD | 341.2 million USD |
| 2014Q1 | 32.2 million USD | 299.4 million USD |
| 2013Q4 | 19.1 million USD | 289.2 million USD |
| 2013Q3 | 30.9 million USD | 292.1 million USD |
| 2013Q2 | 27.3 million USD | 292.9 million USD |
| 2013Q1 | 25.6 million USD | 291.2 million USD |
| 2012Q4 | 18.4 million USD | 280.1 million USD |
| 2012Q3 | 22.0 million USD | 278.7 million USD |
| 2012Q2 | 30.5 million USD | 284.7 million USD |
| 2012Q1 | 26.4 million USD | 286.0 million USD |
| 2011Q4 | 27.1 million USD | 291.0 million USD |
| 2011Q3 | 18.8 million USD | 277.6 million USD |
| 2011Q2 | 32.3 million USD | 288.3 million USD |
| 2011Q1 | 31.3 million USD | 285.8 million USD |
| 2010Q4 | -343.6 million USD | 267.9 million USD |
| 2010Q3 | -24.9 million USD | 276.1 million USD |
| 2010Q2 | 14.5 million USD | 292.1 million USD |
| 2010Q1 | 17.4 million USD | 297.3 million USD |
| 2009Q4 | 17.6 million USD | 295.4 million USD |
| 2009Q3 | 37.3 million USD | 297.5 million USD |
| 2009Q2 | 34.2 million USD | 308.2 million USD |
| 2009Q1 | 25.4 million USD | 301.5 million USD |
| 2008Q4 | -661.9 million USD | 311.4 million USD |
| 2008Q3 | 44.7 million USD | 342.2 million USD |
| 2008Q2 | 50.2 million USD | 352.1 million USD |
| 2008Q1 | 45.2 million USD | 337.7 million USD |
| 2007Q4 | 36.9 million USD | 318.0 million USD |
| 2007Q3 | 42.8 million USD | 314.0 million USD |
| 2007Q2 | 38.0 million USD | 307.4 million USD |
| 2007Q1 | 36.8 million USD | 291.2 million USD |
| 2006Q4 | 35.2 million USD | 271.7 million USD |
| 2006Q3 | -16.6 million USD | 264.7 million USD |
| 2006Q2 | 25.7 million USD | 267.9 million USD |
| 2006Q1 | -100.1 million USD | 283.8 million USD |
| 2005Q4 | 50.4 million USD | 291.2 million USD |
| 2005Q3 | 32.1 million USD | 273.9 million USD |
| 2005Q2 | 31.9 million USD | 283.4 million USD |
| 2005Q1 | 27.6 million USD | 273.7 million USD |
| 2004Q4 | 20.1 million USD | 238.1 million USD |
| 2004Q3 | 25.8 million USD | 176.0 million USD |
| 2004Q2 | 26.3 million USD | 180.2 million USD |
| 2004Q1 | 17.6 million USD | 172.6 million USD |
| 2003Q4 | 20.6 million USD | 156.0 million USD |
| 2003Q3 | 19.6 million USD | 151.2 million USD |
| 2003Q2 | 20.6 million USD | 154.4 million USD |
| 2003Q1 | 19.4 million USD | 152.1 million USD |
| 2002Q4 | 17.5 million USD | 142.9 million USD |
| 2002Q3 | 18.5 million USD | 141.4 million USD |
| 2002Q2 | 16.3 million USD | 136.5 million USD |
| 2002Q1 | -2.2 million USD | 133.8 million USD |
| 2001Q4 | 8.9 million USD | 126.1 million USD |
| 2001Q3 | 10.5 million USD | 123.7 million USD |
| 2001Q2 | 9.0 million USD | 116.8 million USD |
| 2001Q1 | 7.0 million USD | 99.0 million USD |
| 2000Q4 | 4.4 million USD | 90.8 million USD |
| 2000Q3 | -24.3 million USD | 72.4 million USD |
| 2000Q2 | 8.0 million USD | 74.1 million USD |
| 2000Q1 | 636000 USD | 69.3 million USD |
CRL Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 474.6 million USD | 4.1 billion USD |
| 2022 | 486.2 million USD | 4.0 billion USD |
| 2021 | 391.0 million USD | 3.5 billion USD |
| 2020 | 364.3 million USD | 2.9 billion USD |
| 2019 | 252.0 million USD | 2.6 billion USD |
| 2018 | 226.4 million USD | 2.3 billion USD |
| 2017 | 123.4 million USD | 1.9 billion USD |
| 2016 | 154.8 million USD | 1.7 billion USD |
| 2015 | 149.3 million USD | 1.4 billion USD |
| 2014 | 126.7 million USD | 1.3 billion USD |
| 2013 | 102.8 million USD | 1.2 billion USD |
| 2012 | 97.3 million USD | 1.1 billion USD |
| 2011 | 109.6 million USD | 1.1 billion USD |
| 2010 | -336.7 million USD | 1.1 billion USD |
| 2009 | 114.4 million USD | 1.2 billion USD |
| 2008 | -521.8 million USD | 1.3 billion USD |
| 2007 | 154.4 million USD | 1.2 billion USD |
| 2006 | -55.8 million USD | 1.1 billion USD |
| 2005 | 142.0 million USD | 1.1 billion USD |
| 2004 | 89.8 million USD | 766.9 million USD |
| 2003 | 80.2 million USD | 613.7 million USD |
| 2002 | 50.1 million USD | 554.6 million USD |
| 2001 | 35.4 million USD | 465.6 million USD |
| 2000 | -11.2 million USD | 306.6 million USD |
| 1999 | 17.1 million USD | 219.3 million USD |
| 1998 | 23.4 million USD | 193.3 million USD |
CRL
Price: $233.47
52 week price:
Earnings Per Share: 9.22 USD
P/E Ratio: 23.66
Exchange: NYQ
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 411300
Ebitda: 110.3 millionMarket Capitalization: 12.9 billion
Average Dividend Frequency: 11